Management of neonatal and infancy-onset diabetes mellitus

Endocrine Development

Volumn 11, Issue , 2007, Pages 94-105

  Sovik O ^a   Tansek, M ^c   Sagen, J ^a   Njolstad P ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY CHILDREN S HOSPITAL   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; GLUCOKINASE;

CHILD; CHROMOSOME 6; CHROMOSOME ABERRATION; DIABETES MELLITUS; GENETICS; GENOME IMPRINTING; HUMAN; INCIDENCE; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; NEWBORN; ONSET AGE; PRESCHOOL CHILD; REVIEW; SYNDROME;

AGE OF ONSET; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 6; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; GENOMIC IMPRINTING; GLUCOKINASE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; KATP CHANNELS; SYNDROME;

EID: 39549123264     PISSN: 14217082     EISSN: 16622979     Source Type: Book Series    
DOI: 10.1159/000111062     Document Type: Conference Paper

References (50)

1. Njølstad PR, Søvik O, Cuesta-Munoz A, Bjørkhaug L, Massa O, Barbetti F, Undlien DE, Shiota C, Magnuson MA, Molven A, Matschinsky FM, Bell GI: Neonatal diabetes mellitus due to complete glucokinase deficiency. N Engl J Med 2001;344:1588-1592.
2. Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS, Howard N, Srinivasan S, Silva JM, Molnes J, Edghill EL, Frayling TM, Temple IK, Mackay D, Shield JP, Sumnik Z, van Rhijn A, Wales JK, Clark P, Gorman S, Aisenberg J, Ellard S, Njølstad PR, Ashcroft FM, Hattersley AT: Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 2004;350:1838-1849.
3. Proks P, Arnold AL, Bruining J, Girard C, Flanagan SE, Larkin B, Colclough K, Hattersley AT, Ashcroft FM, Ellard S: A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes. Hum Mol Genet 2006;15:1793-1800.
4. Babenko AP, Polak M, Cave H, Busiah K, Czernichow P, Scharfmann R, Bryan J, Aguilar-Bryan L, Vaxillaire M, Froguel P: Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. N Engl J Med 2006;355:456-466.
5. Delepine M, Nicolino M, Barrett T, Golamaully M, Lathrop GM, Julier C: EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome. Nat Genet 2000;25:406-409.
6. Temple IK, Shield JP: Transient neonatal diabetes, a disorder of imprinting. J Med Genet 2002;39:872-875.
7. Sagen JV, Raeder H, Hathout E, Shehadeh N, Gudmundsson K, Baevre H, Abuelo D, Phornphutkul C, Molnes J, Bell GI, Gloyn AL, Hattersley AT, Molven A, Søvik O, Njølstad PR: Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy. Diabetes 2004;53:2713-2718.
8. Pearson ER, Flechtner I, Njølstad PR, Malecki MT, Flanagan SE, Larkin B, Ashcroft FM, Klimes I, Codner E, Iotova V, Slingerland AS, Shield J, Robert JJ, Holst JJ, Clark PM, Ellard S, Søvik O, Polak M, Hattersley AT: Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 2006;355:467-477.
9. Imerslund O: The prognosis in diabetes with onset before age two. Acta Paediatr 1959;49:243-248.
10. Pundziute-Lyckå A, Dahlquist G, Nyström L, Arnqvist H, Björk E, Blohmé G, Bolinder J, Eriksson JW, Sundkvist G, Östman J: The incidence of type I diabetes has not increased but shifted to a younger age at diagnosis in the 0-34 years group in Sweden 1983-1998. Diabetologia 2002;45:783-791.
11. Woolley SL, Saranga S: Neonatal diabetes mellitus: a rare but important diagnosis in the critically ill infant. Eur J Emerg Med 2006;13:349-351.
12. Jeffersen IG, Smith MA, Baum JD: Insulin-dependent diabetes in under 5 years olds. Arch Dis Child 1985;60:1144-1148.
13. Mjellem N, Schirmer L, Søvik O: Childhood diabetes with onset before the age of two years (Norwegian). Tidsskr Nor Laegeforen 1991;111:2547-2548.
14. Iafusco D, Stazi MA, Cotichini R, Cotellessa M, Martinucci ME, Mazzella M, Cherubini V, Barbetti F, Martinetti M, Cerutti F, Prisco F: Permanent diabetes mellitus in the first year of life. Diabetologia 2002;45:798-804.
15. Rosenbauer J, Herzig P, von Kries R, Neu A, Giani G: Temporal, seasonal, and geographical incidence patterns of type I diabetes mellitus in children under 5 years of age in Germany. Diabetologia 1999;42:1055-1059.
16. Cilio CM, Bosco S, Moretti C, Farilla L, Savignoni F, Colarizi P, Multari G, Di Mario U, Bucci G, Dotta F: Congenital autoimmune diabetes mellitus. N Engl J Med 2000;342:1529-1531.
17. Mazzella M, Bellini C, Bertini IM, Massocco DS, Cotellessa M, Serra G: Evidence of autoimmunity in male twins with neonatal diabetes. Diabetes Care 2001;24:408.
18. Fösel S: Transient and permanent neonatal diabetes. Eur J Pediatr 1995;154:944-948.
19. Mühlendahl KE, Herkenhoff H: Long-term course of neonatal diabetes. N Engl J Med 1995;333:704-708.
20. Oseid S, Søvik O, Aagenaes Ø: Idiopathic neonatal hyperglycemia. 13th Int Congr Pediatr, Trans 1971;7:437-441.
21. Parameswanappa K, Douglas PA: Transient neonatal diabetes mellitus: treatment with chlorpropamide. Am J Dis Child 1979;133:65-66.
22. Pagliara AS, Karl IE, Kipnis DB: Transient neonatal diabetes: delayed maturation of the pancreatic beta cell. J Pediatr 1973;82:97-101.
23. Sodoyez-Goffaux F, Sodoyez JC: Transient diabetes mellitus in a neonate: evaluation of insulin, glucagon, and growth hormone secretion and management with a continuous low-dose insulin infusion. J Pediatr 1977;91:395-399.
24. Nielsen F: Transient neonatal diabetes mellitus in a pair of twins. Acta Paediatr 1989;78:469-472.
25. Slingerland AS: Monogenic diabetes in children and young adults: challenges for researcher, clinician and patient. Rev Endocr Metab Disord 2006;7:171-185.
26. Hattersley AT, Bruining J, Shield J, Njølstad PR, Donaghue K: ISPAD Clinical Practice Consensus Guidelines 2006-2007: the diagnosis and management of monogenic diabetes in children. Pediatr Diabetes 2006;7:352-360.
27. Milner AD: Blood glucose and serum insulin levels in children with cystic fibrosis. Arch Dis Child 1969;44:351-355.
28. Lombardi F, Raia V, Spagnuolo MI, Nugnes R, Valerio G, Ciccarelli G, Franzese A: Diabetes in an infant with cystic fibrosis. Pediatr Diabetes 2004;5:199-201.
29. Siahanidou T, Mandyla H, Doudounakis S, Anagnostakis D: Hyperglycaemia and insulinopenia in a neonate with cystic fibrosis. Acta Paediatr 2005;94:1837-1840.
30. Casas L, Berry DR, Logan K, Copeland KC, Royall JA: Cystic fibrosis related diabetes in an extremely young patient. J Cyst Fibros 2007;6:247-249.
31. Njølstad PR, Sagen JV, Bjørkhaug L, Odili S, Shehadeh N, Bakry D, Sarici SU, Alpay F, Molnes J, Molven A, Søvik O, Matschinsky FM: Permanent neonatal diabetes caused by glucokinase deficiency: inborn error of the glucose-insulin signaling pathway. Diabetes 2003;52:2854-2860.
32. Porter JR, Shaw NJ, Barrett TG, Hattersley AT, Ellard S, Gloyn AL: Permanent neonatal diabetes in an Asian infant. J Pediatr 2005;146:131-133.
33. Gloyn AL, Reimann F, Girard C, Edghill EL, Proks P, Pearson ER, Temple IK, Mackay DJ, Shield JP, Freedenberg D, Noyes K, Ellard S, Ashcroft FM, Gribble FM, Hattersley AT: Relapsing diabetes can result from moderately activating mutations in KCNJ11. Hum Mol Genet 2005;14:925-934.
34. Colombo C, Delvecchio M, Zecchino C, Faienza MF, Cavallo L, Barbetti F: Transient neonatal diabetes mellitus is associated with a recurrent (R201H) KCNJ11 (KIR6.2) mutation. Diabetologia 2005;48:2439-2441.
35. Zung A, Glaser B, Nimri R, Zadik Z: Glibenclamide Treatment in Permanent Neonatal Diabetes Mellitus due to an Activating Mutation in Kir6.2. J Clin Endocrinol Metab 2004;89:5504-5507.
36. Codner E, Flanagan S, Ellard S, Garcia H, Hattersley AT: High-Dose Glibenclamide Can Replace Insulin Therapy Despite Transitory Diarrhea in Early-Onset Diabetes Caused by a Novel R201L Kir6.2 Mutation. Diabetes Care 2005;28:758-759.
37. Massa O, Iafusco D, D'Amato E, Gloyn AL, Hattersley AT, Pasquino B, Tonini G, Dammacco F, Zanette G, Meschi F, Porzio O, Bottazzo G, Crino A, Lorini R, Cerutti F, Vanelli M, Barbetti F: KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes. Hum Mutat 2005;25:22-27.
38. Tonini G, Bizzarri C, Bonfanti R, Vanelli M, Cerutti F, Faleschini E, Meschi F, Prisco F, Ciacco E, Cappa M, Torelli C, Cauvin V, Tumini S, Iafusco D, Barbetti F: Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene. Diabetologia 2006;49:2210-2213.
39. Proks P, Girard C, Baevre H, Njølstad PR, Ashcroft FM: Functional Effects of Mutations at F35 in the NH2-terminus of Kir6.2 (KCNJ11), Causing Neonatal Diabetes, and Response to Sulfonylurea Therapy. Diabetes 2006;55:1731-1737.
40. Hathout E, Mace J, Bell GI, Njølstad PR: Treatment of hyperglycemia in a 7-year-old child diagnosed with neonatal diabetes. Diabetes Care 2006;29:1458.
41. Stanik J, Gasperikova D, Paskova M, Barak L, Javorkova J, Jancova E, Ciljakova M, Hlava P, Michalek J, Flanagan SE, Pearson E, Hattersley AT, Ellard S, Klimes I: Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ 11 and ABCC8 mutation carriers. J Clin Endocrinol Metab 2007;in press.
42. Slingerland AS, Nuboer R, Hadders-Algra M, Hattersley AT, Bruining GJ: Improved motor development and good long-term glycaemic control with sulfonylurea treatment in a patient with the syndrome of intermediate developmental delay, early-onset generalised epilepsy and neonatal diabetes associated with the V59M mutation in the KCNJ11 gene. Diabetologia 2006;49:2559-2563.
43. Mackay DJ, Boonen SE, Clayton-Smith J, Goodship J, Hahnemann JM, Kant SG, Njølstad PR, Robin NH, Robinson DO, Siebert R, Shield JP, White HE, Temple IK: A maternal hypomethylation syndrome presenting as transient neonatal diabetes mellitus. Hum Genet 2006;120:262-269.
44. Stoss H, Pesch HJ, Pontz B, Otten A, Spranger J: Wolcott-Rallison syndrome: diabetes mellitus and spondyloepiphyseal dysplasia. Eur J Pediatr 1982;138:120-129.
45. Komulainen J, Kulmala P, Savola K, Lounamaa R, Ilonen J, Reijonen H, Knip M, Akerblom HK: Childhood Diabetes in Finland (DiMe) Study Group: Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Diabetes Care 1999;22:1950-1955.
46. Bland GL, Wood VD: Diabetes in infancy: diagnosis and current management. J Natl Med Assoc 1991;83:361-365.
47. Nimri R, Phillip M, Shalitin S: Children diagnosed with diabetes during infancy have unique clinical characteristics. Horm Res 2006;67:263-267.
48. Grunt JA, Banion CM, Ling L, Siegel C, Frost M: Problems in the care of the infant diabetic patient. Clin Pediatr (Phila) 1978;17:772-774.
49. Lteif AN, Schwenk WF 2nd: Type 1 diabetes mellitus in early childhood: glycemic control and associated risk of hypoglycemic reactions. Mayo Clin Proc 1999;74:211-216.
50. Wintergerst KA, Hargadon S, Hsiang HY: Continuous subcutaneous insulin infusion in neonatal diabetes mellitus. Pediatr Diabetes 2004;5:202-206.